ArticleBiomedicines2023

Combination Therapy with Trastuzumab and Niraparib: Quantifying Early Proliferative Alterations in HER2+ Breast Cancer Models.

Ameer Mansur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.